Latest Lead News

Kuniko Limited has launched a partially underwritten rights issue to fund exploration at its Commonwealth Gold-Silver Project in New South Wales, aiming to capitalise on high-grade multi-metal potential in a Tier-1 jurisdiction.

Austral Resources Australia Ltd is advancing its strategy to become a mid-tier copper producer by consolidating key assets in Queensland’s Mount Isa copper belt, supported by a $40 million capital raise.

Alterity Therapeutics has raised A$20 million through a strategic placement to advance its promising ATH434 treatment for Multiple System Atrophy, backed by encouraging Phase 2 trial results. The capital injection strengthens the company’s balance sheet as it prepares for regulatory discussions with the FDA.

Theta Gold Mines appoints Hansjoerg Plaggemars as non-executive director and promotes Bill Richie Yang to executive director, bolstering financial and project development leadership as the TGME Gold Mine Project advances.

M3 Mining Limited has raised $2.25 million through a share placement to fund exploration at its Victorian projects and pursue strategic acquisitions, signaling a renewed focus under new leadership.

Lode Resources reports exceptional high-grade antimony and silver drill results from its Montezuma Project in Tasmania, including the deepest mineralised intercept to date at 220m. These findings bolster the potential for a significant bulk tonnage resource amid soaring metal prices.

Frontier Digital Ventures reported a 5% decline in revenue but a striking 71% jump in EBITDA for the first half of 2025, driven by margin expansion and operational efficiencies across its classifieds marketplaces in emerging regions.

Marimaca Copper has successfully raised A$80 million through a strongly supported placement, positioning the company to advance exploration and development at its flagship Chilean copper projects.

4DMedical has secured multi-year agreements to deploy its advanced lung imaging technology across Brazil and Australia, supporting national lung cancer screening programs and enhancing lung health diagnostics.

Finder Energy is fast-tracking its Kuda Tasi and Jahal development with advanced engineering and critical FPSO evaluations, aiming for a Final Investment Decision in 2026. This acceleration seeks to reduce risks and optimize costs ahead of production.

Domino’s Pizza Enterprises faces ASX scrutiny following a steep share price fall after its FY25 results, with regulators seeking clarity on earnings disclosures and market expectations.

Cambium Bio has secured a strategic partnership with French pharmaceutical leader Benta SAS to commercialise its regenerative dry eye treatment, Elate Ocular, across Europe and the Middle East. This follows a second platelet-lysate licensing deal within days, underscoring growing industry confidence in Cambium’s platform.